SCHEMBL4593852

SCHEMBL4593852

Cc1nc(Nc2ncc(C#N)s2)cc(O[C@H]2CCNC2)n1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDR P35968 13/20 0.43
CHEK1 O14757 6/20 0.38
KCNH2 Q12809 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4586348 0.94 KDR (0.47) KDR
SCHEMBL4587497 0.84 KDR (0.43) KDR
SCHEMBL4585514 0.83 KDR (0.46) KDRCHEK1
SCHEMBL4587518 0.83 KDR (0.46) KDR
SCHEMBL4592951 0.79 KDR (0.50) KDR
SCHEMBL4594057 0.79 KDR (0.49) KDR
SCHEMBL4586120 0.79 KDR (0.60) KDRCHEK1
SCHEMBL4616997 0.78 KDR (0.54) KDR
SCHEMBL4593903 0.78 KDR (0.44) KDR
SCHEMBL4593901 0.77 KDR (0.44) KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558609-A4 KINASE INHIBITORS MERCK & CO INC (US) 2008-05-28 EP claimed
EP-1558609-A2 KINASE INHIBITORS Merck & Co., Inc. (US) 2005-08-03 EP claimed
WO-2004041164-A2 KINASE INHIBITORS MERCK & CO., INC. (US) 2004-05-21 WO claimed
EP-1558609-A4 KINASE INHIBITORS MERCK & CO INC (US) 2008-05-28 EP disclosed
EP-1558609-A2 KINASE INHIBITORS Merck & Co., Inc. (US) 2005-08-03 EP disclosed
WO-2004041164-A2 KINASE INHIBITORS MERCK & CO., INC. (US) 2004-05-21 WO disclosed